Ramsay Health Care (ASX:RHC) Announces Two Non-Recurring Items
Ramsay Health Care (ASX:RHC) announces two non-recurring items impacting its 1H FY25 financial results, including UK segment impairment and tax provision release.
Category: Healthcare
Alterity Therapeutics (ASX:ATH) Raises A$40 Million in Placement
Alterity Therapeutics (ASX:ATH) secures A$40 million to advance ATH434 development for Parkinsonian disorders, supported by institutional investors.
Careteq Limited (ASX:CTQ) Announces Strategic Partnership with MedicAlert Foundation
Careteq Limited (ASX:CTQ) forms a strategic partnership with MedicAlert Foundation Australia to enhance medication safety for Australians.
Wellnex Life Limited (ASX:WNX) Announces Entitlement Offer
Wellnex Life Limited (ASX:WNX) launches a non-renounceable entitlement offer to raise $22.1 million for strategic growth and debt redemption.
BTC Health (ASX:BTC) Expands Distribution Partnership with Arna Pharma
BTC Health (ASX:BTC) extends partnership with Arna Pharma, securing indefinite license and royalty agreements in key markets.
Micro-X Ltd (ASX:MX1) Raises $3.3M in Capital Placement
Micro-X Ltd (ASX:MX1) successfully raises $3.3M through capital placement, focusing on medical imaging and strategic partnerships.
CLINUVEL Pharmaceuticals Limited (ASX:CUV) Reports Preliminary CUV052 Study Results
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
Smartgroup Corporation Ltd (ASX:SIQ) Secures Monash Health Contract for Salary Packaging
Smartgroup Corporation Ltd (ASX:SIQ) secures a contract with Monash Health to provide salary packaging and novated leasing services for 25,000 employees.
PYC Therapeutics (ASX:PYC) Receives Approval to Begin Human Trials for PKD Treatment
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.
Radiopharm Theranostics (ASX:RAD) Reports Successful Detection of Brain Metastases with RAD 101
Radiopharm Theranostics (ASX:RAD) announces successful clinical trial results for RAD 101 in detecting brain metastases, advancing their oncology portfolio.